Bronchiectasis

Bronchiectasis Causes

Bronchiectasis causes

Bronchiectasis Causes

There are several known causes of bronchiectasis. Cystic fibrosis – a genetic condition that causes the production of excess mucus – is one of the most common. In fact, these two conditions are so frequently correlated that some physicians use the term “CF bronchiectasis” to refer to bronchiectasis caused by cystic fibrosis.

Conversely, the classification “non-CF bronchiectasis” can be used to refer to cases of bronchiectasis that are linked to other causes. These other potential causes include:

  • Autoimmune diseases such as rheumatoid arthritis
  • Human immunodeficiency virus (HIV)
  • Hypersensitivities to certain allergens
  • Inflammatory bowel disease, ulcerative colitis or Crohn’s disease
  • Alpha-1 antitrypsin deficiency
  • Chronic obstructive pulmonary disease (COPD)
  • Connective tissue diseases such as Marfan’s disease or Williams-Campbell syndrome
  • Traumatic lung injuries
  • The presence of tumors or other foreign bodies in the lungs

Bronchiectasis can trigger severe scarring and inflammation in the lungs, which in turn causes mucus to develop. Mucus can obstruct the airways and make a person more prone to infection. Researchers have spent many years studying ways to interrupt this cycle of inflammation, mucus production and obstruction. Stem cell therapy is one alternative treatment that – unlike most other therapies for bronchiectasis – has the potential to slow the progression of the disease. Stem cell treatment may also be able to help alleviate many of the symptoms that bronchiectasis causes, such as chest pain and difficulty breathing. Many of the individuals who have turned to the Lung Institute for stem cell treatment have experienced an improvement in their quality of life.

If you’re seeking treatment for bronchiectasis, contact the Lung Institute at (800) 729-3065 to learn more about stem cell therapy. We understand that bronchiectasis often causes a number of inconvenient symptoms, but our caring team is here to help you find relief.

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. The Lung Institute is firmly in accordance with the conditions set by the FDA for exemption status and conducts itself in full accordance with current guidelines. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and stem cell procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.